Gilead Sciences has gifted Georgia 10 000 units of antiviral drug Remdesivir, worth USD 4 million.
As the Head of Infectious Diseases and AIDS Centre said, this drug is successfully used to treat coronavirus.
“Georgia’s experience showed that in the early stages of the disease, the drug was beneficial for oxygen-dependent patients. It significantly reduced the patient’s risk for exacerbation and long-term hospitalization. On top of that, the drug sped up recovery.
It should be mentioned that Gilead Sciences supported the country’s national HCV elimination plan since its launch in 2015, saving 74,000 patients living with hepatitis C”, - added Tengiz Tsertsvadze.